Astria Therapeutics Inc
ATXS
Mkt cap
$382.06M
EV/Sales
N/A
P/E ratio
N/A
Revenue (qtr ended 2025-09-30)
$706,000
EPS (9mo ended 2025-09-30)
$-1.70
Gross Margin (qtr ended 2025-09-30)
N/A
Profit Margin (qtr ended 2025-09-30)
-13938.24%
Beta
0.38
Div yield
N/A
Sector
Healthcare
No recent filings in cache.
Astria Therapeutics Inc (ATXS) is a biotechnology company listed on US.
Latest reported ATXS revenue for 2025-09-30 was $706.0K. Net income was -$98.4M. ATXS currently screens at market cap $382.1M.
Use this ATXS research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ATXS income, balance, and cash tables.
Astria Therapeutics Inc (ATXS) is a biotechnology company in the Healthcare sector.
Latest cached Astria Therapeutics Inc (ATXS) revenue for Sep 30, 2025 was $706.0K. Net income was -$98.4M. Statements: https://lician.com/financials/atxs
Astria Therapeutics Inc (ATXS) market capitalization is $382.1M on the latest cached snapshot.